Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Healthtrust
Julphar
Baxter
Argus Health
Chinese Patent Office
Medtronic
Express Scripts
McKesson
Queensland Health

Generated: January 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,344,840

« Back to Dashboard

Summary for Patent: 5,344,840
Title: 4-substituted imidazole derivatives useful in perioperative care
Abstract:4-[1-(2,3-dimethylphenyl)ethyl]-1H-imidazole, known as medetomidine, and in particular its d-enantiomer and salts thereof are useful in perioperative care, in particular in reducing the amount of anaesthetic it is necessary to administer.
Inventor(s): Maze; Mervyn (Portola Valley, CA), Scheinin; Mika (Naantali, FI)
Assignee: Orion-Yhtyma OY (Turku, FI)
Application Number:08/003,681
Patent Claim Types:
see list of patent claims
Use;

Drugs Protected by US Patent 5,344,840

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,344,840

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom8804683Feb 29, 1988

International Patents Family Members for US Patent 5,344,840

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 101514 ➤ Subscribe
Australia 3027289 ➤ Subscribe
Australia 611262 ➤ Subscribe
Canada 1338556 ➤ Subscribe
Germany 68913054 ➤ Subscribe
Denmark 175282 ➤ Subscribe
Denmark 46489 ➤ Subscribe
European Patent Office 0331374 ➤ Subscribe
United Kingdom 2215206 ➤ Subscribe
United Kingdom 8804683 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Covington
Julphar
Queensland Health
Teva
Boehringer Ingelheim
McKesson
Federal Trade Commission
Daiichi Sankyo
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot